Want to see JP:2934 full AI Analyst Report?
J Frontier Co., Ltd. (2934) AI Stock Analysis
J Frontier Co., Ltd.
(TSE/TYO:2934)
The overall score is 42, reflecting a high-risk profile. The primary drag is the company's poor financial performance, characterized by unprofitable operations and a dangerously leveraged balance sheet, which is compounded by a negative P/E ratio. The neutral technical trend provides some stability but does not outweigh the fundamental weaknesses.
J Frontier Co., Ltd. (2934) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 10.18B
- Dividend Yield
- ―
- Average Volume (3M)
- 7,113
- Price to Earnings (P/E)
- -33.9
- Beta (1Y)
- 0.04
- Revenue Growth
- 9.77%
- EPS Growth
- -470.54%
- Country
- Japan
- Employees
- 201
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
J Frontier Co., Ltd. Business Overview & Revenue Model
Company Description
J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription d...
How the Company Makes Money
Detailed, source-backed information on J Frontier Co., Ltd.’s revenue model (e.g., primary revenue streams, segment mix, pricing/fee structure, and material partnerships) was not available in the provided context. null
J Frontier Co., Ltd. Financial Statement Overview
Summary
Financial health is weak. While revenue growth is strong, profitability is poor with recurring net losses and declining margins. The balance sheet is highly leveraged (D/E > 4x) with dwindling equity, posing significant risk. Positive operating cash flow is a lone bright spot but insufficient to offset the high debt burden.
Income Statement
35NegativeBalance Sheet
25NegativeCash Flow
45Neutral| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.08B | 22.24B | 21.50B | 17.71B | 11.88B | 16.84B |
| Gross Profit | 8.77B | 8.36B | 18.17B | 8.33B | 5.40B | 7.12B |
| EBITDA | 1.01B | 963.76M | 914.54M | -1.22B | 760.66M | -1.54B |
| Net Income | 69.27M | -321.31M | 87.57M | -2.09B | 400.52M | -1.90B |
Balance Sheet | ||||||
| Total Assets | 8.83B | 9.59B | 9.17B | 11.41B | 6.10B | 7.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 2.16B | 2.17B | 1.81B | 2.96B | 1.65B |
| Total Debt | 4.04B | 5.31B | 4.34B | 5.16B | 544.39M | 2.14B |
| Total Liabilities | 6.83B | 8.05B | 7.16B | 9.53B | 1.94B | 4.54B |
| Stockholders Equity | 1.37B | 1.23B | 1.41B | 1.14B | 4.14B | 2.48B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 395.24M | 447.19M | -1.54B | -377.40M | -1.94B |
| Operating Cash Flow | 0 | 454.32M | 509.01M | -1.44B | -366.94M | -1.83B |
| Investing Cash Flow | 0 | -1.13B | 470.79M | -1.79B | -860.09M | -1.13B |
| Financing Cash Flow | 0 | 693.89M | -623.13M | 3.39B | 2.56B | 1.45B |
J Frontier Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Neutral. The current price of 1908.00 is below the 20-day moving average (MA) of 1967.15, below the 50-day MA of 1992.66, and above the 200-day MA of 1650.86, indicating a neutral trend. The MACD of -14.26 indicates Positive momentum. The RSI at 38.25 is Neutral, neither overbought nor oversold. The STOCH value of 53.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2934.
J Frontier Co., Ltd. Peers Comparison
Overall Rating
JP:448372Outperform
JP:921867.8Neutral
JP:448063Neutral
JP:443850Neutral- JP:293442Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4483 | 72Outperform | JPY 241.50B | 33.42 | ― | 0.51% | 18.89% | 11.66% |
| JP:9218 | 68Neutral | JPY 8.05B | 33.60 | ― | 1.32% | 27.65% | -28.38% |
| JP:4480 | 63Neutral | JPY 75.89B | 38.64 | 12.35% | ― | 24.03% | 34.50% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4438 | 50Neutral | JPY 2.36B | -4.51 | ― | ― | 14.84% | 30.67% |
| JP:2934 | 42Neutral | JPY 10.41B | -33.91 | ― | ― | 9.77% | -470.54% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2934 | J Frontier Co., Ltd. | 1908.00 | 91.00 | 5.01% | |
| JP:4480 | Medley, Inc. | 2323.00 | 191.00 | 8.96% | |
| JP:4438 | Welby Inc. | 282.00 | -7.00 | -2.42% | |
| JP:4483 | JMDC Inc. | 3540.00 | -1326.33 | -27.26% | |
| JP:9218 | Mental Health Technologies Co. Ltd. | 760.00 | -75.34 | -9.02% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026